May 12, 2006, Newsletter Issue #15: Bextra and the FDA
Tip of the Week
Bextra was approved by the FDA in 2001 to treat the severe pain associated with osteoarthritis, rheumatoid arthritis, menstrual cramps, and a number of other chronic pain conditions. Originally these drugs were designed to provide effective pain relief without the harmful gastrointestinal side effects associated with original NSAIDs like naproxen and ibuprofen. It was pulled from the market in 2005.
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
